EMT-affected cells exhibit increased expression of drug efflux pump genes, resistance to cancer cell adhesion to ECM components such as collagen and fibronectin, or growth in a stiff matrix, which promotes chemotherapy resistance [322]. This evidence concerns the gene FN1 and cancer.